DiscovHER PAN-206: Phase 2 tumour-agnostic study of Zanidatamab in patients with previously treated human epidermal growth factor receptor 2 (HER2)-overexpressing solid tumours.
Saved in:
| Title: | DiscovHER PAN-206: Phase 2 tumour-agnostic study of Zanidatamab in patients with previously treated human epidermal growth factor receptor 2 (HER2)-overexpressing solid tumours. |
|---|---|
| Authors: | Subbiah, Vivek1 (AUTHOR), Makker, Vicky2 (AUTHOR), Oh, Do-Youn3 (AUTHOR), Gardener, Elizabeth4 (AUTHOR), Gartner, Elaina5 (AUTHOR), Meric-Bernstam, Funda6 (AUTHOR) |
| Source: | Gynecologic Oncology. May2026:Supplement, Vol. 208, pS144-S145. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
